Primary Antibodies
Secondary Antibodies
Proteins & Peptides
ELISA Kits
About Us
Contact Us
Antibodies.com Logo Antibodies.com Logo
Sign In/Register
0
ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Recombinant SARS-CoV-2 Spike Protein (B.1.351 Variant) (Functional) (A269990)

SDA-PAGE - Recombinant SARS-CoV-2 Spike Protein (B.1.351 Variant) (Functional) (A269990) - Antibodies.com Functional Studies - Recombinant SARS-CoV-2 Spike Protein (B.1.351 Variant) (Functional) (A269990) - Antibodies.com Functional Studies - Recombinant SARS-CoV-2 Spike Protein (B.1.351 Variant) (Functional) (A269990) - Antibodies.com
$690
Product Datasheet
100% Guarantee
Price Match Guarantee
Request a Quotation
Custom or Bulk Request

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 4-6 business days.

  • Specifications

Name
Recombinant SARS-CoV-2 Spike Protein (B.1.351 Variant) (Functional)
Description
Full-length soluble protein with foldon trimerization motif, mutated Furin recognition site and 4 stabilising mutations (A892P, A942P, K986P and V987P), based on/modified from Amanat et al, 2020 (PMID: 32398876) and Hsieh et al, 2020 (PMID: 32703906).
Applications
WB, SDS-PAGE, Immunoassays, Functional Studies
Expression System
HEK293 cells.
Protein Species
SARS-CoV-2
Protein Length
Protein fragment.
Sequence
VNFTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFANPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRGLPQGFSALEPLVDLPIGINITRFQTLHISYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGNIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVKGFNCYFPLQSYGFQPTYGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRGAGSVASQSIIAYTMSLGVENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGPALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTPSALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDPPEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKSGGSGYIPEAPRDGQAYVRKDGEWVLLSTFLGSHHHHHHHH
Amino Acids
16 to 1211
Tag
His Tag (8xHis at the C-terminus).
Predicted MW
137 kDa (including tags).
Biologically Active
Yes
Purity
> 95% (by SDS-PAGE).
Purification
Affinity chromatography.
Product Form
Liquid
Concentration
Lot Specific
Formulation
Supplied in Phosphate Buffered Saline with 20% Glycerol.
Endotoxin Level
< 0.1 ng/µg (1 IEU/µg), as measured by LAL method.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -70°C. Avoid freeze/thaw cycles.
General Notes
Also known as the beta Variant of Concern, B.1.351 variant (South Africa, L18F, D80A, D215G, ?242-244, R246I, K417N, E484K, N501Y, D614G, and A701V).
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.

  • Scientific Validation DataValidation Data (3)

SDA-PAGE - Recombinant SARS-CoV-2 Spike Protein (B.1.351 Variant) (Functional) (A269990) - Antibodies.comEnlarge Image

Recombinant SARS-CoV-2 Spike Protein (B.1.351 Variant) (Functional) (A269990)

Recombinant SARS-CoV-2 Spike Protein (B.1.351 Variant) (Functional) on SDS-PAGE. The gel was stained with Instant Blue Stain. The purity of the protein is greater than 95%. Estimated molecular weight (SDS-PAGE) of 190 kDa.
Functional Studies - Recombinant SARS-CoV-2 Spike Protein (B.1.351 Variant) (Functional) (A269990) - Antibodies.comEnlarge Image

Recombinant SARS-CoV-2 Spike Protein (B.1.351 Variant) (Functional) (A269990)

Recombinant SARS-CoV-2 Spike Protein (B.1.351 Variant) (Functional) was immobilised on 96-well plates as the capture antigen. Human serum samples from a serological verification panel containing Anti-SARS-CoV-2 Antibodies from National Institute of Biological Standards and Controls, NIBSC (20/B770), were added to the plate for incubation and subsequent washing. Secondary Anti-Human IgG Antibodies (HRP) were added for detection in a sandwich ELISA format. The final colorimetric reaction occurs upon addition of TMB substrate which is quenched by the addition of acid solution.
Functional Studies - Recombinant SARS-CoV-2 Spike Protein (B.1.351 Variant) (Functional) (A269990) - Antibodies.comEnlarge Image

Recombinant SARS-CoV-2 Spike Protein (B.1.351 Variant) (Functional) (A269990)

Binding curve of Anti-COVID-19 & SARS-CoV S Glycoprotein Antibody [CR3022] to Recombinant SARS-CoV-2 Spike Protein (B.1.351 Variant) (Functional).
Publishing research using Recombinant SARS-CoV-2 Spike Protein (B.1.351 Variant) (Functional) (A269990)? Please let us know so that we can list the citation on this page.